YM155, a selective survivin inhibitor, reverses chronic hypoxic pulmonary hypertension in rats via upregulating voltage-gated potassium channels
Author:
Publisher
Informa UK Limited
Subject
General Medicine,Physiology,Internal Medicine
Link
http://www.tandfonline.com/doi/pdf/10.3109/10641963.2014.987390
Reference35 articles.
1. Acute Oxygen-Sensing Mechanisms
2. Emerging therapies for the treatment of pulmonary hypertension
3. Hypoxia-Induced Pulmonary Vascular Remodeling
4. Role of apoptosis in pulmonary hypertension: From experimental models to clinical trials
5. Emerging Concepts and Translational Priorities in Pulmonary Arterial Hypertension
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension;Frontiers in Pharmacology;2023-04-24
2. Survivin knockdown alleviates pathological hydrostatic pressure-induced bladder smooth muscle cell dysfunction and BOO-induced bladder remodeling via autophagy;Frontiers in Cell and Developmental Biology;2022-10-28
3. Effects of YM155 on the proliferation and apoptosis of pulmonary artery smooth muscle cells in a rat model of high pulmonary blood flow-induced pulmonary arterial hypertension;Clinical and Experimental Hypertension;2022-05-04
4. Angiotensin‑converting enzyme 2 alleviates pulmonary artery hypertension through inhibition of focal adhesion kinase expression;Experimental and Therapeutic Medicine;2021-08-12
5. Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway;Molecular Medicine Reports;2021-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3